Humacyte (HUMA) Receivables (2020 - 2026)

Humacyte (HUMA) reported Receivables of $434000.0 for Q1 2026, down 11.07% year-over-year from $488000.0 in Q1 2025, and down 1.59% quarter-over-quarter from $441000.0 in Q4 2025.

Humacyte (HUMA) Receivables (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has 5 years of Receivables data on file, last reported at $434000.0 in Q1 2026.

  • Receivables for Q1 2026 came in at $434000.0, down 11.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $434000.0 (down 11.07% YoY), and the FY2025 annual result was $441000.0, changed N/A from the prior year.
  • Receivables eased to $434000.0 in Q1 2026 per HUMA's latest filing, from $441000.0 in the prior quarter.
  • Over five years, Receivables peaked at $1.3 million in Q2 2022 and troughed at $31000.0 in Q3 2022.
  • A 3-year average of $492333.3 and a median of $434000.0 in 2026 frame the typical range for Receivables.
  • The sharpest annual moves came in 2022 and 2026: Receivables slumped 87.08% in 2022, then slipped 11.07% in 2026.
  • A 3-year view of Receivables shows it stood at $31000.0 in 2022, then surged by 1322.58% to $441000.0 in 2025, then decreased by 1.59% to $434000.0 in 2026.
  • Business Quant data shows HUMA's Receivables at $434000.0 in Q1 2026, $441000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 13.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 2.00 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Humacyte 267.09 Mn 218.55 Mn -1.54 Mn 434,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 434,000.00
Dec 31, 2025 441,000.00
Sep 30, 2025 1.08 Mn
Jun 30, 2025 394,000.00
Mar 31, 2025 488,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 1.30 Mn
Mar 31, 2022 233,000.00
Dec 31, 2021 176,000.00
Sep 30, 2021 240,000.00
Dec 31, 2020 113,000.00